| Filed On | Filing |
|---|---|
| 22 Apr 2026 |
Form 3: Ettenberg Felecia, Chief Legal Officer
Holds 237,000 shares of Common Stock |
| 03 Apr 2026 |
Form 3: Dinavahi Rajani, Chief Medical Officer
Holds 201,000 shares of Common Stock |
| 07 Nov 2025 |
Form 3: Hohenleitner Susan, Chief Financial Officer
Holds 146,896 shares of Common Stock |
| 17 Oct 2025 |
Form 3: Bishop John E, See Remarks
Holds 218,000 shares of Common Stock |
| 17 Oct 2025 |
Form 3: Conner Edward R., Chief Medical Officer
Holds 302,260 shares of Common Stock |
| 17 Oct 2025 |
Form 3: Brady James Parker, Chief Human Resources Officer
Holds 166,000 shares of Common Stock |
| 13 May 2025 |
Form 3: Parsey Merdad, Director
No securities owned |
| 19 Nov 2024 |
Form 3: Reilly Joseph James, See Remarks
Holds 120,000 shares of Common Stock |
| 16 Aug 2024 |
Form 3: Foster Eric Duane, Chief Commercial Officer
No securities owned |
| 27 Mar 2024 |
Form 3: Kelliher Mike, See Remarks
No securities owned |
| 23 Jun 2022 |
Form 3: Williams Laura A, Chief Medical Officer
Holds 243,717 shares of Common Stock |
| 18 Mar 2022 |
Form 3: Felsch Robert Ora, See Remarks
Holds 88,418 shares of Common Stock |
| 15 Mar 2021 |
Form 3: Bhanji Muna, Director
No securities owned |
| 22 Jun 2020 |
Form 3: Blanks Robert, See Remarks
Holds 115,395 shares of Common Stock |
| 22 Jun 2020 |
Form 3: Jacobs Jeffrey W, Chief Scientific Officer
Holds 145,566 shares of Common Stock |
| 08 Jun 2020 |
Form 3: Renz Justin A, Chief Financial Officer
Holds 3,000 shares of Common Stock |
| 19 May 2020 |
Form 3: Rodriguez Susan, Chief Commercial Officer
No securities owned |
| 07 Apr 2020 |
Form 3: Santorelli Keith, See Remarks
No securities owned |
| 16 Mar 2020 |
Form 3: Cadoret-Manier Onaiza, Director
No securities owned |
| 18 Mar 2019 | Form 3: Block Geoffrey A., Director |
Loading...
